SCHEMBL20127191

SCHEMBL20127191

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(C4(c5ccccc5)c5ccccc5-c5c4ccc4c5oc5ccccc54)cc3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
HPGD P15428 2/20 0.36
MAPT P10636 11/20 0.35
LMNA P02545 6/20 0.35
KMT2A Q03164 6/20 0.35
POLB P06746 3/20 0.35
TSHR P16473 3/20 0.35
HTT P42858 1/20 0.35
ALOX5 P09917 1/20 0.35
KDM4E B2RXH2 4/20 0.34
MEN1 O00255 5/20 0.34
OPRK1 P41145 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34
GAA P10253 2/20 0.34
HSD17B10 Q99714 2/20 0.33
USP2 O75604 1/20 0.33
PGR P06401 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23951219 0.93 ALOX5 (0.34) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL17307408 0.91 MAPT (0.38) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL30818204 0.88 PGR (0.39) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL18382952 0.88 PGR (0.39) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL18156703 0.88 MAPT (0.37) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL18463304 0.88 ALOX5 (0.42) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL20127216 0.88 ALOX5 (0.36) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL16855375 0.88 MAPT (0.36) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL18156835 0.87 ALOX5 (0.36) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL18156717 0.87 ALOX5 (0.36) ALDH1A1HPGDMAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745362-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2020-08-18 US disclosed
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM LTD. (KR) 2018-05-10 US disclosed
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM LTD. (KR) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10745362-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 ALDH1A1 526/4885HPGD 2180/4885MAPT 1073/4885
US-20180127385-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 ALDH1A1 526/4885HPGD 2180/4885MAPT 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.